In summary, our results suggest that QMR treatment in in vitro model of osteoarthritis-related inflammation reduces proinflammatory mediators and nitrosative stress in immune cells by inhibiting COX-2 and iNOS protein expression as well as reducing NF-κB activity and peroxynitrite levels. Here, NFKB1 is linked to osteoarthritis.